Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$737M |
| 2 |
American Tower
AMT
|
+$687M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$554M |
| 4 |
Abbott
ABT
|
+$553M |
| 5 |
SLB Ltd
SLB
|
+$449M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.06B |
| 2 |
Netflix
NFLX
|
+$816M |
| 3 |
Match Group
MTCH
|
+$678M |
| 4 |
NVIDIA
NVDA
|
+$611M |
| 5 |
Intuitive Surgical
ISRG
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.87% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Northrop Grumman
NOC
$77.1B
| $29.9M | 0.03% |
62,579
+28,357
| +83% | +$13M |
|
|
SNCY
252
DELISTED
Sun Country Airlines
SNCY
| $29.7M | 0.03% |
1,617,418
+45,616
| +3% | +$1.07M |
|
|
SWAV
253
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $29.6M | 0.03% |
154,641
-278,893
| -64% | -$49.2M |
|
|
HOLX
254
DELISTED
Hologic
HOLX
| $29.4M | 0.03% |
423,824
-229,875
| -35% | -$17.1M |
|
255
Lennar Class A
LEN
$19.8B
| $29.3M | 0.03% |
428,966
-20,853
| -5% | -$1.53M |
|
256
Lazard
LAZ
$4.13B
| $29.1M | 0.03% |
896,856
+31,346
| +4% | +$1.06M |
|
257
Inspire Medical Systems
INSP
$1.45B
| $29M | 0.03% |
158,936
-49,878
| -24% | -$9.95M |
|
258
Nordson
NDSN
$16.6B
| $29M | 0.03% |
143,332
-124,812
| -47% | -$26.6M |
|
259
JD.com
JD
$44.6B
| $28.8M | 0.03% |
448,252
+1,900
| +0.4% | +$110K |
|
260
Marvell Technology
MRVL
$168B
| $28.7M | 0.03% |
658,278
+91,227
| +16% | +$5.17M |
|
261
Pinduoduo
PDD
$126B
| $28.6M | 0.03% |
+462,295
| New | +$21.7M |
|
|
CDMO
262
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $28.6M | 0.03% |
1,871,569
+610,382
| +48% | +$9.03M |
|
263
Cooper Companies
COO
$14.1B
| $28.5M | 0.03% |
363,628
+5,916
| +2% | +$524K |
|
264
Aptiv
APTV
$12B
| $28.4M | 0.03% |
318,611
-12,517
| -4% | -$1.28M |
|
|
PACW
265
DELISTED
PacWest Bancorp
PACW
| $28.3M | 0.03% |
1,061,452
-173,667
| -14% | -$5.62M |
|
266
Adecoagro
AGRO
$1.44B
| $28.3M | 0.03% |
3,342,748
+1,312,982
| +65% | +$14.1M |
|
|
SPR
267
DELISTED
Spirit AeroSystems
SPR
| $28.2M | 0.03% |
963,645
+99,926
| +12% | +$3.58M |
|
268
Hershey
HSY
$35.2B
| $28M | 0.03% |
130,303
+31,073
| +31% | +$6.77M |
|
269
Amphenol
APH
$198B
| $27.5M | 0.03% |
854,860
-422,780
| -33% | -$14.7M |
|
270
DuPont de Nemours
DD
$18.5B
| $27.5M | 0.03% |
393,806
-9,159
| -2% | -$750K |
|
271
ExxonMobil
XOM
$644B
| $27.1M | 0.03% |
315,856
-60,406
| -16% | -$5.45M |
|
272
TotalEnergies
TTE
$195B
| $27M | 0.03% |
513,322
+50,030
| +11% | +$2.67M |
|
|
UMH
273
UMH Properties
UMH
$1.29B
| $26.6M | 0.03% |
1,508,144
+296,853
| +25% | +$6.17M |
|
274
WSFS Financial
WSFS
$4.12B
| $26.5M | 0.03% |
662,008
-113,081
| -15% | -$4.65M |
|
275
FIVE9
FIVN
$2.11B
| $26.5M | 0.03% |
290,567
-81,735
| -22% | -$8.27M |
|
Similar funds
Jennison Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Jennison Associates held 720 positions worth $100B, down 26% from $136B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Jennison Associates withdrew a net $3.7B in Q2 2022, closing 106 positions and reducing 265 holdings. Its most notable exit was Okta, an estimated $272M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in KBR worth $40.4M.
- Jennison Associates's largest Q2 2022 buy was KBR: 834,334 shares worth $40.4M.
- Jennison Associates added most to Eli Lilly in Q2 2022, an estimated $737M increase.
- Jennison Associates's biggest Q2 2022 reduction was Shopify, cutting an estimated $1.06B.
- Jennison Associates fully exited Okta in Q2 2022, selling an estimated $272M.
- Jennison Associates's ten largest holdings make up 41% of its $100B portfolio in Q2 2022.
- Jennison Associates opened 95 new positions and closed 106 in Q2 2022.
- Jennison Associates's portfolio value fell 26% quarter-over-quarter to $100B.
Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.